MeVis Medical Solutions AG (FRA:M3V)
Germany flag Germany · Delayed Price · Currency is EUR
26.00
+0.20 (0.78%)
Last updated: Apr 24, 2025

FRA:M3V Statistics

Total Valuation

FRA:M3V has a market cap or net worth of EUR 47.68 million. The enterprise value is 41.16 million.

Market Cap 47.68M
Enterprise Value 41.16M

Important Dates

The next estimated earnings date is Tuesday, May 27, 2025.

Earnings Date May 27, 2025
Ex-Dividend Date Mar 26, 2025

Share Statistics

Current Share Class n/a
Shares Outstanding n/a
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 479,388

Valuation Ratios

The trailing PE ratio is 10.46.

PE Ratio 10.46
Forward PE n/a
PS Ratio 2.81
PB Ratio 2.67
P/TBV Ratio 2.67
P/FCF Ratio 16.76
P/OCF Ratio 15.16
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.00, with an EV/FCF ratio of 14.47.

EV / Earnings 9.02
EV / Sales 2.42
EV / EBITDA 10.00
EV / EBIT 10.34
EV / FCF 14.47

Financial Position

The company has a current ratio of 4.13

Current Ratio 4.13
Quick Ratio 4.13
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is 25.59% and return on invested capital (ROIC) is 13.96%.

Return on Equity (ROE) 25.59%
Return on Assets (ROA) 9.13%
Return on Invested Capital (ROIC) 13.96%
Return on Capital Employed (ROCE) 16.47%
Revenue Per Employee 169,717
Profits Per Employee 45,608
Employee Count 100
Asset Turnover 0.62
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +1.56% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change +1.56%
50-Day Moving Average 25.78
200-Day Moving Average 24.94
Relative Strength Index (RSI) 55.66
Average Volume (20 Days) 284

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, FRA:M3V had revenue of EUR 16.97 million and earned 4.56 million in profits. Earnings per share was 2.51.

Revenue 16.97M
Gross Profit 6.43M
Operating Income 3.98M
Pretax Income 4.69M
Net Income 4.56M
EBITDA 4.11M
EBIT 3.98M
Earnings Per Share (EPS) 2.51
Full Income Statement

Balance Sheet

The company has 6.53 million in cash and n/a in debt, giving a net cash position of 6.53 million.

Cash & Cash Equivalents 6.53M
Total Debt n/a
Net Cash 6.53M
Net Cash Per Share n/a
Equity (Book Value) 17.83M
Book Value Per Share 9.79
Working Capital 7.24M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 3.15 million and capital expenditures -301,911, giving a free cash flow of 2.84 million.

Operating Cash Flow 3.15M
Capital Expenditures -301,911
Free Cash Flow 2.84M
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 37.91%, with operating and profit margins of 23.46% and 26.87%.

Gross Margin 37.91%
Operating Margin 23.46%
Pretax Margin 27.62%
Profit Margin 26.87%
EBITDA Margin 24.25%
EBIT Margin 23.46%
FCF Margin 16.76%

Dividends & Yields

This stock pays an annual dividend of 0.95, which amounts to a dividend yield of 3.65%.

Dividend Per Share 0.95
Dividend Yield 3.65%
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield 3.65%
Earnings Yield 9.56%
FCF Yield 5.97%
Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

FRA:M3V has an Altman Z-Score of 4.9.

Altman Z-Score 4.9
Piotroski F-Score n/a